35th Annual Meeting of the European Group for Blood and Marrow Transplantation
25th Meeting of the EBMT Nurses Group
8th Meeting of the EBMT Data Management Group
3rd Patient & Family Day
Göteborg, Sweden
29.03.2009 - 01.04.2009

Please select a day:

Personal programme

Please enter your email address here in order to bring up your personal programme

Home - 30.03.2009

Monday, March 30, 2009
17:30 - 19:00

Physicians Poster Session

Multiple myeloma

		Lenalidomide therapy increases the frequency of activated T- and NK-cells in patients with relapsed multiple myeloma following allogeneic stem cells transplantation	P 585
		M. Lioznov, P. Freiberger, Y. Hildebrandt, U. Bacher, A. Zander, N. Kröger (Hamburg, DE)
		Thalidomide + dexamethasone as maintenance after single autologous stem cell transplantation improves progression-free survival in advanced multiple myeloma. A prospective Brazilian randomised trial	P 586
		A. Maiolino, V. Hungria, G. Oliveira-Duarte, D. Mercante, E.C.M. Miranda, A. Quero, A. Miguel Peres, P. Tanaka, L. Oliveira, R. Magalhães, E. Rego, M Nucci, I Lorand-Metze, C. Lima, I. Zalcberg, E. Braggio, C. de Souza (Rio de Janeiro, São Paulo, Campinas, Ribeirão Preto, BR)
		Application of the propensity score matching method to the estimation of survival benefit of non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first autologous transplantation	P 587
		L. Karlin, B. Arnulf, S. Chevret, M. Robin, R. Peffault de Latour, M. Malphettes, N. Kabbara, B. Asli, L. Ades, V. Rocha, J.-P. Fermand, G. Socié (Paris, FR)
		Outcomes in patients with multiple myeloma following autologous stem cell transplantation using intravenous busulfan and melphalan: a matched comparison to a double autologous transplant strategy conditioned with melphalan and CBV	P 588
		M. Blanes, J. de la Rubia, J.J. Lahuerta, J.D. González, P. Ribas, C. Solano, A. Alegre, M.A. Sanz (Valencia, Madrid, Las Palmas, ES)
		Effect of plerixafor plus G-CSF on tumour cell mobilisation in patients with multiple myeloma	P 589
		S. Fruehauf, J. Topaly, S. Muller, M. Moos, H. Goldschmidt, A.D. Ho, G. Calandra (Heidelberg, DE; Cambridge, US)
		Outpatient stem cell transplantation for multiple myeloma	P 590
		A. Ghavamzadeh, K. Alimoghaddam, A. Karimi, A. Manookian, M Asadi, R. Maheri, A.R. Shamshiri (Tehran, IR)
		Detrimental effect of platelet contamination on the quality of stem cells products collected to autograft patients with multiple myeloma	P 591
		A. Leon, L. Garderet, C. Soler, H. Rouard, N.C. Gorin , P. Bierling (Paris, FR)
		Is there a curative potential of autologous stem cell transplantation in multiple myeloma? Long-term results from a single-centre series	P 592
		M. Rovira, L. Rosiñol, F. Fernández-Avilés, C. Martínez, E. Giné, J. Esteve, M.T. Cibeira, P. Marín, E. Carreras, J. Bladé (Barcelona, ES)
		Autologous peripheral blood stem cell transplantation in 5 patients affected by POEMS syndrome	P 593
		L. Laurenti, S. De Matteis, P. Chiusolo, N. Piccirillo, F. Sorà, M. Tarnani, S. Bellesi, C. Giannotta, E. Nobile Orazio, G. Leone, S. Sica (Rome, Rozzano Milan, IT)
		Bortezomib and lenalidomide for multiple myeloma patients relapsed after allogeneic stem cell transplantation	P 594
		P. Corradini, V. Montefusco, B. Bruno, E. Merla, R. Sorasio, A. Olivieri, A. Falcone, L. Giaccone, L. Farina, F. Spina, A. Dodero, R. Milani, A.M. Carella, N. Cascavilla (Milan, Turin, San Giovanni Rotondo, Potenza, IT)
		Ethnicity and autologous stem cell transplantation in myeloma	P 595
		H. Auner, C. Giles, J. Pavlu, E. Olavarria, D. Macdonald, E. Kanfer, J. Apperley, A. Rahemtulla (London, UK)
		Vinorelbine and pegfilgrastim for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: a predictive and cost-effective procedure	P 596
		M.J. Bargetzi, T. Pabst, A. Schoenenberger, J. Burger, P. Fernandez, P. Moosmann, A.R. Huber, M. Wernli, M. Heizmann (Aarau, Berne, CH)
		Genetic prognostic factors and the outcome of autologous stem cell transplantation in plasma cell disorders	P 597
		M. Dávid, S. Kosztolányi, Á. Szomor, D. Alpár, B. Kajtár, Á. Nagy, G. Kovács, R. Csalódi, J. Hermesz, J. Tábori, C. Szalontay, H. Losonczy, L. Pajor (Pécs, HU)
		CD66A expression on plasma cells from multiple myeloma patients	P 598
		C.H. Lee, B. Guinn, S. Brooks, D. Richardson, K. Orchard (Southampton, UK)
		Regional differences in haematopoietic stem cell activity in South East England: a multi-centre investigation of inequalities in utilisation and inequity of access to treatment for multiple myeloma	P 599
		H. Owiti, J. Apperley (London, UK)
		Plerixafor plus G-CSF is effective without significant toxicity in PBSC mobilisation from myeloma patients with dialysis-dependent renal failure who have failed to mobilise by conventional means: an initial series of three patients	P 600
		K.W. Douglas, P.J. Hayden, M.E. O'Dwyer, A. Rahemtulla (Glasgow, UK; Galway, IE; London, UK)
		Severe renal impairment is not a major limit for autologous stem cell transplantation in patients with multiple myeloma or amyloidosis	P 601
		V. Fiaccadori, F. Ripamonti, A. Colombo, P. Bernasconi, D. Caldera, M. Merli, C. Elena, G. Pica, E.P. Alessandrino (Pavia, IT)
		Short-course pretransplant velcade, thalidomide and dexamethasone regimen induces high complete response rate without compromising CD34+ cell collection in untreated multiple myeloma patients: preliminary results of a single-centre experience	P 602
		E. Pennese, M. Dargenio, M.R. De Paolis, P. Forese, R. Matera, G. Pugliese, G. Reddiconto, A. Valacca, C. Vergine, N. Di Renzo (Lecce, IT)
		11 years of single-centre experience with stem cell transplantation for multiple myeloma	P 603
		J. Radocha, V. Maisnar, P. Zak, A. Zavrelova, M. Cermanova, M. Kmonicek, L. Jebavy, J. Maly (Hradec Kralove, CZ)
		Autologous haematopoietic progenitor cell transplantation followed by a reduced-intensity conditioning and allotransplantation in de novo multiple myeloma patients: an update	P 604
		M. Martino, G. Console, E. Spiniello, D. Marcuccio, G. Messina, G. Irrera, R. Fedele, E. Massara, I. Bova, T. Moscato, M. Cuzzola, P. Iacopino (Reggio Calabria, IT)
		Impact of low-dose thalidomide as maintenance therapy in advanced multiple myeloma patients following high-dose therapy	P 605
		A. Andreini, F. Randon, C. Tecchio, G. Quaresmini, F. Frattini, R. Di Bella, M. Sorio, S. Ledro, C. Perbellini, D. de Sabata, F. Benedetti (Verona, IT)
		Impact of pretransplantation, mobilisation and graft variables on transplant outcome after autologous haematopoietic stem cell transplantation for patients with multiple myeloma	P 606
		M. Michallet, M. Sobh, Q.-H. Le, F. Barraco, C. Dumontet, Y. Chelghoum, E. Nicolas-Virelizier, X. Thomas, A. Praire, C. Plesa, G. Cannas, F.E. Nicolini, J. Troncy (Lyon, FR)
		Lenalidomide as salvage therapy after allogeneic transplant for primary plasma cell leukaemia: a case report	P 607
		I. Attolico, M. Cimminiello, G. Discepoli, R.A. Cifarelli, M. Pizzuti, N. Filardi, M. Poggiaspalla, D. Vertone, A. Olivieri (Potenza, Ancona, Metaponto (MT), IT)
		Tolosa-Hunt-like syndrome in a myeloma patient receiving palifermin shortly after high-dose melphalan therapy	P 608
		S. Mueller, H. Steffen, F. Wendel, M. Kreissl, R. Seggewiss, H. Einsele, S. Knop (Würzburg, DE)
		Autologous peripheral blood stem cell transplantation in patient in advanced stage of POEMS syndrome	P 609
		M. Cioch, J. Manko, A. Dmoszynska (Lublin, PL)

Monday, March 30, 200917:30 - 19:00

Physicians Poster Session

Multiple myeloma

Monday, March 30, 2009
17:30 - 19:00